Ignite Creation Date:
2024-05-06 @ 12:12 PM
Last Modification Date:
2024-10-26 @ 12:55 PM
Study NCT ID:
NCT03702439
Status:
COMPLETED
Last Update Posted:
2022-01-27
First Post:
2018-10-02
Brief Title:
Prostate Cancer Screening Trial Using Imaging
Sponsor:
Imperial College London
Organization:
Imperial College London
Study Overview
Official Title:
Prostate Cancer Screening Trial Using A Group of Radiological Approaches Including MRI and Ultrasound
Status:
COMPLETED
Status Verified Date:
2022-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PROSTAGRAM
Brief Summary:
Participants will be recruited from the community and attend a screening clinic and undergo the following screening tests
1 Bi-parametric MRI - reported by a radiologist and CAD-AI system
2 Multiparametric ultrasound - including shearwave elastography
3 A standard-of-care PSA test
A systematic - targeted biopsy will be performed if any tests are positive independent of the other tests
1 Bi-parametric MRI - reported by a radiologist and CAD-AI system
2 Multiparametric ultrasound - including shearwave elastography
3 A standard-of-care PSA test
A systematic - targeted biopsy will be performed if any tests are positive independent of the other tests
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None